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Abstract
The growing use of the Metabolic Syndrome in pediatric age need a critical approach, on the basis
of recent concerns on definition and usefulness for individual management in clinical practice. We
reviewed these aspects from a pediatric point of view, providing a set of questions about what the
Metabolic Syndrome means in a clinical setting. The new proposed pediatric definition by IDF was
discussed, by outlying how it does not fully consider the peculiarities of children and adolescents.
The comparison between two cases of obese children was used in order to show how this
diagnosis could be confusing for a correct management. We stressed the need for health-related
limits for each component of the Metabolic Syndrome instead of percentile-derived cut-points, as
well as the opportunity to extend the estimation to other family or individual risk factors by means
of a multiple-items screening form. In conclusion, Metabolic Syndrome use in pediatric age suffers
at present from important limitations (i.e., adult derived definition, possibility to rule-in but not to
rule-out the individual metabolic risk, instability of MetS during adolescence, poor usefulness of the
diagnosis for specific treatment). Consequently, a prudent use of Metabolic Syndrome for children
and adolescents seems to be the best and honest position for paediatricians, waiting for long term,
longitudinal follow-up studies that could clarify the entire question.
Introduction
A recent scientific statement from the American Heart
Association and other related Committees focussed the
topic of the Metabolic Syndrome (MetS) in pediatric age
[1]. The paper provided a set of fundamental questions
about what the pediatric MetS means in clinical or
research setting. The Authors concluded defining limits of
our current knowledge and providing suggestions for
needed future research [1]. This position paper outlined
most of the concerns that pediatricians feel about the use-
fulness of MetS diagnosis in day by day clinical practice.
Concerns also are referred to which MetS definition has to
be used for children. Controversies are mainly related to
two diverging approaches: one adapting the definition of
MetS from adults [2-4], the other considering the peculi-
arities of children and adolescents [5,6].
Aim of the present paper is to discuss difficulties found by
pediatricians facing to MetS definition and usefulness.
Discussion
Metabolic syndrome definition
Metabolic syndrome is the clustering of specific metabolic
abnormalities found in overweight and obese subjects,
but present also in some normal weight subjects. In
adults, the presence of three among clinical (obesity or
abdominal obesity, hypertension) and metabolic param-
eters (hyperglycemia, high triglycerides, low HDL-choles-
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terol) is used to define MetS [2-4]. In the last decade,
many studies in paediatrics derived MetS definition from
those used for adults, mostly adapting cut-off points for
each parameter to children or adolescents. For this pur-
pose, the percentile methodology was generally used.
Recently, the International Diabetes Federation (IDF) pro-
posed a new pediatric definition according to age groups
[7]. In particular, IDF suggested that the MetS should not
be diagnosed in children younger than 10 yrs, while for
subjects 10 to 16 years they proposed the use of adult IDF
MetS definition [3] with the only difference represented
by waist 90th percentile instead of absolute values. There-
fore, the IDF defined a 10-16 yrs old subject as having the
MetS if waist circumference was ≥ the 90th percentile and
if two other of the following items were above or under a
single cut-point: triglycerides ≥ 150 mg/dl, HDL < 40 mg/
dl, glucose ≥ 100 mg/dl, systolic or diastolic blood pres-
sure (BP) ≥ 130 or ≥ 85 mmHg, respectively [7].
Despite the pediatric IDF definition is becoming to be
used in epidemiological studies [8,9], pediatricians face
these proposed new limits. Glucose cut-point corresponds
to that proposed by the American Diabetes Association
few years ago with a general agreement [10], as well as the
90th waist circumference percentile is a worldwide consid-
ered and accepted limit [11]. On the contrary, the use of
single cut-points for high triglycerides and low HDL, inde-
pendently from the known age- and gender-related varia-
tions in this age group, is particularly striking due to the
pubertal impact on lipid parameters [12].
Hypertension diagnosis in pediatric age
The most discussed limit among those proposed by IDF is
the single blood pressure (BP) cut-point (i.e., 130 for
systolic or 85 for diastolic) instead of those related to age,
gender and height. Up to now, the risk for hypertension
was generally set at the 95th percentile level according to
National Health Blood Pressure Education Program
(NHBPEP) chart [13]. It appears that the difference
between the two limits can be conspicuous, especially for
younger subjects with lowest height percentiles, and
therefore that a certain degree of underestimation of
hypertension could derive from the application of IDF
proposal. The main question is whether the pediatrician
should prefer the use of single BP limit (130/85), derived
from adult clinical surveys and linked to health conse-
quences [14], instead of the use of multiple (up to 84 cou-
ple of values in this age interval) age, gender, and height-
related limits [13]. However, the latter cumbersome
approach seems to be justified by the known variation of
BP values in pediatric subjects due to the mentioned vari-
ables. At the same time it is striking that an unique BP
limit for hypertension risk could work in adult population
with subjects of different ages and height ranging even
from 150 to 200 cm. In other words, is there an excessive
complication of hypertension diagnosis by pediatricians,
or a simplification of it for adult doctors, or maybe both?
The question remains open. Recently, the discussion on
hypertension diagnosis in pediatrics was stimulated by
the publication of a simplified table of BP values to be
used for screening hypertension risk. This proposal sug-
gested to use, for each age group and gender, the 90th per-
centile usually applied for shorter children (5th height
percentile) [15] in order to avoid undiagnosed hyperten-
sion, an approach which seems to take the opposite direc-
tion than that of the IDF definition [7]. At the same time,
a recent paper together with the accompanying editorial
[16,17] rose other doubts on pediatric hypertension diag-
nosis, up to now based on normative values instead of on
health-related ones. In any case, until this point will be
clarified by further longitudinal surveys, it seem prefera-
ble for pediatric hypertension diagnosis the use of the
more prudent NHBPEP strategy instead of the IDF pro-
posal [7].
Metabolic Syndrome usefulness in clinical practice
In Table 1 we show comparison between 2 obese boys 12
years old with similar excessive BMI and increased waist
circumference. The diagnosis of MetS can be done only in
the case #1 according to the pediatric definition [7], while
in the case #2 we can found the presence of only 2 abnor-
mal parameters. Nevertheless, if we look to other variables
not included in the set for MetS, we note that the case #2
shows a clustering of both familial and individual factors
which can be considered closely associated with meta-
bolic risk. Recently it was demonstrated the relevant
importance of positive family history for type 2 diabetes
and other CVD-related diseases in the prediction of future
health and risk for MetS [18,19]. Therefore, we feel that
we cannot estimate an higher risk for case #1 respect to
case #2 on the basis of the presence of MetS diagnosis
alone. Even in the absence of an overt metabolic pattern,
as represented by the MetS, the paediatrician should
extend the analysis by looking for the presence of other
factors (familial or individual) which could confer to that
child a potential future risk. We should also highlight the
limitations of a dichotomous definition of the MetS, by
preferring a continuous indicator [6,20], or the use of a
multiple-items screening form [5].
Taking into consideration MetS diagnosis, we could sug-
gest that its presence in a child could be useful for rule-in
but not for rule-out a risk for future health. In fact, there is
the possibility of having a false negative estimation in
those children not (yet) achieving MetS diagnosis but hav-
ing other potential factors. In other words, the presence of
one cardiovascular risk factor should raise suspicion that
additional risk factors may also be present and encourage
further investigation [21]. Moreover, it has been proposed
that hepatic steatosis should be considered as an addi-Italian Journal of Pediatrics 2009, 35:41 http://www.ijponline.net/content/35/1/41
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tional diagnostic criterion to be added in future approach
to this problem [22].
On the other hand we need to consider the clinical value
of MetS diagnosis for subject's management. MetS can be
considered the clustering of specific conditions and meta-
bolic disorders, but none of them is required to be clini-
cally severe. In fact, the diagnosis can be done by the
presence of an increased abdominal adiposity together
with pre-hypertension or mild lipid abnormalities, and
does not necessarily imply the presence of hypertension,
dyslipidemia or reduced glucose tolerance, diseases for
which a specific diagnosis is already available. As a conse-
quence of this statement, no specific treatment is strictly
necessary in order to manage these findings, except for
lifestyle and nutritional changes needed for a correction of
excess weight. Therefore, the MetS diagnosis seems not
useful for individual treatment, but it can be considered
helpful for understanding the possible underlying patho-
genesis and for addressing further investigations. Empha-
sis should be given to the presence of physical inactivity
when aiming to estimate the individual metabolic risk, as
an impressive mass of data are now confirming the effect
of the degree of physical fitness for its prevention in child-
hood [23-27].
Finally, a certain degree of instability has been described
in adolescents with MetS during a 3-year observational
study in which almost half of previously affected subjects
lost their condition [28]. Another recent study confirmed
the MetS variability in pediatric age [29].
Conclusions
We must support the need for consensus and further stud-
ies on MetS, as stated by the American Heart Association
[1]. The main questions to be solved are: 1) is it really safe
that a child younger than 10 years should not be diag-
nosed? 2) which is the clinical cost of considering a 10-16
years adolescent like an adult? 3) is it mandatory to iden-
tify cut-points related with future health risk instead of
normative ones in pediatric age?
Until these points will be ascertained, we strongly suggest
to face the topic of MetS taking into consideration that, at
present time, MetS in pediatric age suffers from important
limitations (i.e., adult derived definition, possibility to
rule-in but not to rule-out the individual metabolic risk,
instability of MetS during adolescence, poor usefulness of
the diagnosis for specific treatment).
We think that this should be the best and honest position
that a paediatrician can now apply to MetS in childhood,
waiting for long term, longitudinal follow-up studies that
could clarify the entire question.
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Table 1: Comparison between 2 cases of 12 years old boys for parameters related to metabolic syndrome and other family or 
individual risk factors.
Case #1 Case #2
BMI* 26.5 26.5
Waist circumference** (cm) 86 85
Glucose (mg/dl) 86 85
Triglycerides (mg/dl) 142 115
HDL cholesterol (mg/dl) 38 42
Blood pressure (mmHg) 136/78 132/86
MetS diagnosis, according to [7] yes No
Family history for CVD related diseases (in 1st or 2nd degree) negative DM2, hypertension, dyslipidemia
Birth weight status normal small for gestational age
Early adiposity rebound no yes (at 4 years of age)
*BMI as obese according to Cole et al [30]
** Waist circumference values > 90th percentile according to Fernandez et al [11]
Values over or under the cut-points for MetS according to Zimmet et al [7] are reported in bold character.Publish with BioMed Central    and   every 
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